Feed Insights Top Reports Pricing

⌘K

21:00:47·105d

INSIDERFilingvia Quantisnow

SEC Form 4 filed by insider

ByQuantisnow·Wall Street's wire, on your screen.

CPAY· Corpay Inc.

Real Estate

Plus alert sent

Quantisnow Plus members were alerted at 21:00:51 ET - 4.2s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment CPAY files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CPAY (Corpay Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

GroupPresident Brazil&USVehPmt Netto Armando Lins sold $1,603,307 worth of shares (4,560 units at $351.60), decreasing direct ownership by 29% to 11,274 units (SEC Form 4)
Corpay Cross-Border Named the Official FX Supplier of Vålerenga Fotball AS
Corpay to Participate in Upcoming Investor Conferences
GroupPresident Brazil&USVehPmt Netto Armando Lins sold $6,126,585 worth of shares (17,201 units at $356.18), decreasing direct ownership by 52% to 15,834 units (SEC Form 4)
CEO & Chairman of BOD Clarke Ronald exercised 100,000 shares at a strike of $150.74 and covered exercise/tax liability with 68,150 shares, increasing direct ownership by 1% to 2,408,233 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022